Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Corporate
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
News type
All
Regulatory
Clinical
Conferences
Corporate
Finance
General Meeting
Product candidates
Science & Technology
Other
Subject
All
General Assembly
Company and personnel
GS010 - LUMEVOQ
GS030
Technologies
Other
08 Jun 2020 - 12 Jun 2020
BIO 2020, San Diego (CA), US – Digital
22 April 2020
GenSight Biologics will hold its General Meeting on April 29, 2020 behind closed doors
21 April 2020
GenSight Biologics Reports Cash Position as of March 31, 2020 and Provides Operational Update
08 April 2020
Annual General Meeting on April 29, 2020 Procedures for obtaining preparatory documents for the General Meeting
08 April 2020
GenSight Biologics Announces the Filing of its 2019 Universal Registration Document
06 April 2020
GenSight Biologics Provides Update on Operations in the Context of COVID-19
12 March 2020
GenSight Biologics Reports Full Year 2019 Financial Results and provides an Outlook on 2020
15 Apr 2020 - 17 Apr 2020
2020 Cell & Gene Meeting on the Mediterranean, Barcelona, Spain – cancelled
23 Mar 2020 - 25 Mar 2020
Bio Europe Spring, Paris, France
21 January 2020
GenSight Biologics Reports its Cash Position as of December 31, 2019 and Provides Operational Update
View previous 9 articles
1
…
6
7
8
9
10
11
12
13
14
15
16
17
View next 9 articles
Go back to the page of the page